Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.
“Visual-movement” neurons in the front of your brain can help you stay focused in the presence of visual distractions, according to a new study from neuroscientists in the Perelman School of Medicine at the University of Pennsylvania.
New York University researchers have discovered new cell types in the visual system of flies, made possible by their creation of a tool that finds and labels neurons during development.
Missouri S&T researchers have developed a treatment that could eventually enable glaucoma patients to only use eye drops once per week instead of daily, and it should also be more effective.
A Northwestern Medicine study has uncovered novel cellular mechanisms within the retina, findings that could help advance the development of targeted therapeutics for diseases and conditions affecting vision.
Three-dimensional, lab-grown “mini-corneas” resemble the developing human cornea, making them a powerful new tool for the study of corneal diseases, a study finds.
UConn School of Medicine researchers report that a small population of nerve cells exist in everyone that could be coaxed to regrow, potentially restoring sight and movement after injury.
Medical College of Georgia scientists have early evidence that targeting the bile acid receptor could provide earlier, more impactful treatments for premature babies to prevent retinopathy of prematurity.
Researchers have used artificial intelligence models and machine-learning algorithms to successfully predict which components of amino acids that make up therapeutic proteins are most likely to safely deliver therapeutic drugs to animal eye cells.
Researchers at NIH’s National Eye Institute have published a detailed protocol for making three cell types that are key components to form blood vessels and capillaries.